期刊文献+

奥曲肽对轻症急性胰腺炎的疗效观察 被引量:2

The Effect Observation of Octreotide of Mild Acute Pancreatitis
暂未订购
导出
摘要 目的观察药物奥曲肽对轻症急性胰腺炎的疗效。方法前瞻性将2010年1月至2011年8月收治于我院的110例轻症急性胰腺炎患者随机分为两组,分别为观察组和对照组,其中观察组60例,对照组50例,观察组给予常规治疗+奥曲肽治疗,对照组仅给予常规治疗,回顾性的对两组的不同治疗成果进行对比。结果观察组的上腹压痛消失时间、腹痛缓解时间、血尿淀粉酶恢复正常时间均比对照组所需时间短,且P<0.05,差异具有统计学意义。结论奥曲肽对于轻症急性胰腺炎的药用价值是积极肯定的,可供临床治疗的推广使用。 Objective Observing the light acute pancreatitis curative effect when Octreotide was put into use.Method Prospectively divided the studying cases who were seeing a doctor because of light acute pancreatitis in our hospital from January 2010 to August 2011 into two groups randomly,respectively for the observation group and the matched group.Observation group with 60 cases and matched group with 50 cases.The observation group would be given routine treatment and Octreotide treatment but the matched group would limit to routine treatment.Then compared the different results these two different groups would bring out retrospectively.Results The disappearing time of upper abdomen press pain,the pain remission time of the abdominal pain and the time amylase in blood and urine resumed to normal needed in observation group are all shorter than the matched group needed,and P0.05,stands that the time difference between these two groups is a statistically significant difference.Conclusion Octreotide has a positive and affirmative value in curing the light acute pancreatitis.It deserves of spreading to the clinical treatment of light acute pancreatitis.
作者 熊玉梅
出处 《中国医药指南》 2012年第30期423-425,共3页 Guide of China Medicine
关键词 奥曲肽 轻度急性胰腺炎 疗效 Octreotide Mild acute pancreatitis Efficacy
  • 相关文献

参考文献4

二级参考文献20

  • 1袁耀宗,姚玮艳.急性胰腺炎的发病机制[J].中国实用内科杂志,2004,24(12):706-708. 被引量:63
  • 2沈坤彪,陈友法,沈国富.重症急性胰腺炎29例诊治分析[J].浙江临床医学,2006,8(3):264-264. 被引量:13
  • 3陈训如.微创技术在重症急性胰腺炎及其并发症中的应用[J].中国微创外科杂志,2006,6(5):325-327. 被引量:12
  • 4Nikou GC, Arnaoutis TP, Giamarellos-Bourboulis EJ, et al. The significance of the dosage adjustment of octreotide in the treatment of acutepancreatitis of moderate severity[J]. Hepatogastenterology, 2001,48(42) : 1754-1757.
  • 5Gouillat C, Chipponi J, Baulieux C, et al . Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy [ J] . Br J Surg, 2001 , 88:1456 - 1462.
  • 6Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990 s: pathology,complications,and outcomes [ J] . Ann Surg, 1997, 226(3): 248 -257.
  • 7Buchler MW, Binder M, Friess H. Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis [ J ] .Gut, 1994, 35(Suppl 3): S15 -19.
  • 8Buchler MW, Friess H, Klempa I, et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection [ J] . Am J Surg, 1992, 163 ( 1 ): 125 -130.
  • 9Li LJ , Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of entericutaneous pancreatic fistulas: a systematic review of randomized controlled trials [ J] . Br J Surg, 2001 , 88 (2): 190 -199.
  • 10Andrew M, Lowy M, Jeffrey E, et al . Prospective randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease [ J ] . Ann Surg, 1997 , 226(5): 632 -641.

共引文献93

同被引文献22

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部